Kuros Biosciences AG (SWX:KURN)
Switzerland · Delayed Price · Currency is CHF 22.90
+0.40 (1.78%)
Aug 4, 2026, 12:53 PM CET
Kuros Biosciences AG Market Cap
Kuros Biosciences AG has a market cap or net worth of 887.82 million as of August 4, 2026. Its market cap has decreased by -22.98% in one year.
Market Cap
887.82M
Enterprise Value
873.25M
Revenue
115.82M
Ranking
n/a
PE Ratio
438.90
Stock Price
22.90
ChartMarket Cap Chart
Since January 21, 2016, Kuros Biosciences AG's market cap has decreased from 3.25B to 887.82M, a decrease of -72.68%. That is a compound annual growth rate of -11.58%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2026 | 887.82M | -17.49% |
| Dec 30, 2025 | 1.08B | 33.56% |
| Dec 30, 2024 | 805.64M | 527.99% |
| Dec 29, 2023 | 128.29M | 138.81% |
| Dec 30, 2022 | 53.72M | -14.90% |
| Dec 30, 2021 | 63.13M | -4.70% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 282.27B |
| Novartis AG | 240.63B |
| Galderma Group AG | 41.23B |
| Lonza Group AG | 39.27B |
| Idorsia | 1.56B |
| PolyPeptide Group AG | 1.45B |
| SKAN Group AG | 1.32B |
| Aevis Victoria | 1.10B |